Sort
23,748 grants matching “melanoma”
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$404,582Yin Wang · University Of Maryland Baltimore · R01 · FY2022 · CA
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
$404,530Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$404,489Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Discovery and Clinical Validation of Cancer Biomarkers Using Printed Glycan Array
$404,464Margaret Elisabeth Huflejt · New York University School Of Medicine · U01 · FY2011 · CA
Lymphatic Imaging
$404,455Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The lymph node microenvionment in tumor metastasis
$404,369Judith A. Varner · University Of California, San Diego · R01 · FY2010 · CA
Gulf Coast MBCCOP
$404,351Mobile Infirmary Medical Center · U10 · FY2004 · CA
Novel Immunologic Effects of Semaphorin 7a in IPF
$404,269Erica L Herzog · Yale University · R01 · FY2015 · HL
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
$404,265Pan Zheng · University Of Maryland Baltimore · R01 · FY2019 · CA
Function of ATF2 URE Binding Protein in Human Melanoma
$404,252Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Mitf: A Master Gene for Melanocyte Development
$404,198David E Fisher · Massachusetts General Hospital · R01 · FY2011 · AR
Understanding Resistance to Next Generation Antiandrogens
$404,100Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Understanding Resistance to Next Generation Antiandrogens
$404,100Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
SOUTHWEST ONCOLOGY GROUP
$404,052Wayne State University · U10 · FY2002 · CA
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
$404,020Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2020 · CA
Role of Polo-Like Kinase-1 in Melanocytic Transformation
$403,920Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2015 · AR
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$403,884Andrea Facciabene · University Of Pennsylvania · R01 · FY2020 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$403,864Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
THE GENETICS OF OCULAR MELANOMA
$403,788Anne Mary Bowcock · Imperial College Of Science, Technology And Medicine · R01 · FY2015 · CA
HIV, HERV-K and Human Cancer
$403,750Marie-Louise Hammarskjold · University Of Virginia · R01 · FY2021 · CA
HIV, HERV-K and Human Cancer
$403,750Marie-Louise Hammarskjold · University Of Virginia · R01 · FY2020 · CA
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
$403,742Mei Kong · University Of California-Irvine · R01 · FY2024 · CA